May 17, 2020

NowRx aims to disrupt the pharmacy market

Catherine Sturman
2 min
In a bid to disrupt traditional processes, NowRx will enable patients to re-order repeat prescriptions through utilising Amazon Alexa and Google Cloud t...

In a bid to disrupt traditional processes, NowRx will enable patients to re-order repeat prescriptions through utilising Amazon Alexa and Google Cloud technologies, according to recent reports.

The move will see traditional queues become eradicated within brick-and-mortar pharmacies, and will see prescriptions delivered to a user’s door. Obtaining approximately $2 million in seed funding back in June, NowRx is set to fully launch its service this month.

NowRx CEO Cary Breese has said: "Free same-day delivery provides a dramatically better customer experience, and is uniquely available from an on-demand pharmacy. Large chain pharmacies are reluctant to offer free delivery because of the essential incentive to attract customers into their brick and mortar locations so they can upsell them on all of the other products in the store."

Related stories

"By operating inside highly automated, low-overhead warehouse locations, NowRx will be able to achieve the same or better operating margins as the largest players in the industry and, in fact, we are projecting profitability later this year.”

Furthermore, to appeal to a wider market, NowRx has an inbuilt functionality which deliver reminders for the required medication and refills.

In utilising the technology, users are able to order a repeat prescription through Alexa or Google Home. This request is accepted like a traditional card payment order once the patient’s prescription number is confirmed, and the required medication is delivered promptly. By encrypting any patient data, NowRx are also able to gain HIPAA compliancy by storing this vital patient data away from tech giants.

To further its customer base, the company aim to work with insurance providers with the support of pharmacists and doctors across the US and expand its warehouse operations as it gains increased revenue.

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article